Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome

Abstract Aim To examine the prognostic value of superoxide dismutase (SOD) activity for monitoring reduced left ventricular ejection fraction(LVEF)in the patients with type 2 diabetes and acute coronary syndrome (ACS). Methods The population of this cross-sectional study included 2377 inpatients wit...

Full description

Bibliographic Details
Main Authors: Xiu-Yun Jiang, Qing Chen, Xiao-Yu Chen, Qiu-Ying Sun, Fei Jing, Hai-Qing Zhang, Jin Xu, Xiao-Hong Li, Qing-Bo Guan
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-024-03867-2
_version_ 1797220012003426304
author Xiu-Yun Jiang
Qing Chen
Xiao-Yu Chen
Qiu-Ying Sun
Fei Jing
Hai-Qing Zhang
Jin Xu
Xiao-Hong Li
Qing-Bo Guan
author_facet Xiu-Yun Jiang
Qing Chen
Xiao-Yu Chen
Qiu-Ying Sun
Fei Jing
Hai-Qing Zhang
Jin Xu
Xiao-Hong Li
Qing-Bo Guan
author_sort Xiu-Yun Jiang
collection DOAJ
description Abstract Aim To examine the prognostic value of superoxide dismutase (SOD) activity for monitoring reduced left ventricular ejection fraction(LVEF)in the patients with type 2 diabetes and acute coronary syndrome (ACS). Methods The population of this cross-sectional study included 2377 inpatients with type 2 diabetes who had an ACS admitted to the Shandong Provincial Hospital Affiliated to Shandong First Medical University from January 2016 to January 2021. Results Diabetic patients with ACS were divided into 2 subgroups based on LVEF. The mean SOD activity was significantly lower in patients with an LVEF ≤ 45% than in those with an LVEF > 45% (149.1 (146.4, 151.9) versus 161.9 (160.8, 163.0)). Using ROC statistic, a cut-off value of 148.8 U/ml indicated an LVEF ≤ 45% with a sensitivity of 51.6% and a specificity of 73.7%. SODs activity were found to be correlated with the levels of NT-proBNP, hs-cTnT, the inflammatory marker CRP and fibrinogen. Despite taking the lowest quartile as a reference (OR 0.368, 95% CI 0.493–0.825, P = 0.001) or examining 1 normalized unit increase (OR 0.651, 95% CI 0.482–0.880, P = 0.005), SOD activity was found to be a stronger predictor of reduced LVEF than CRP and fibrinogen, independent of confounding factors. Conclusions Our cross-sectional study suggests that SOD activity might be a valuable and easily accessible tool for assessing and monitoring reduced LVEF in the diabetic patients with ACS.
first_indexed 2024-04-24T12:42:46Z
format Article
id doaj.art-94e3d23389f64182b843135ebd0b8f30
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-04-24T12:42:46Z
publishDate 2024-04-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-94e3d23389f64182b843135ebd0b8f302024-04-07T11:07:43ZengBMCBMC Cardiovascular Disorders1471-22612024-04-012411810.1186/s12872-024-03867-2Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndromeXiu-Yun Jiang0Qing Chen1Xiao-Yu Chen2Qiu-Ying Sun3Fei Jing4Hai-Qing Zhang5Jin Xu6Xiao-Hong Li7Qing-Bo Guan8Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityInternational Medical Service Department, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityAbstract Aim To examine the prognostic value of superoxide dismutase (SOD) activity for monitoring reduced left ventricular ejection fraction(LVEF)in the patients with type 2 diabetes and acute coronary syndrome (ACS). Methods The population of this cross-sectional study included 2377 inpatients with type 2 diabetes who had an ACS admitted to the Shandong Provincial Hospital Affiliated to Shandong First Medical University from January 2016 to January 2021. Results Diabetic patients with ACS were divided into 2 subgroups based on LVEF. The mean SOD activity was significantly lower in patients with an LVEF ≤ 45% than in those with an LVEF > 45% (149.1 (146.4, 151.9) versus 161.9 (160.8, 163.0)). Using ROC statistic, a cut-off value of 148.8 U/ml indicated an LVEF ≤ 45% with a sensitivity of 51.6% and a specificity of 73.7%. SODs activity were found to be correlated with the levels of NT-proBNP, hs-cTnT, the inflammatory marker CRP and fibrinogen. Despite taking the lowest quartile as a reference (OR 0.368, 95% CI 0.493–0.825, P = 0.001) or examining 1 normalized unit increase (OR 0.651, 95% CI 0.482–0.880, P = 0.005), SOD activity was found to be a stronger predictor of reduced LVEF than CRP and fibrinogen, independent of confounding factors. Conclusions Our cross-sectional study suggests that SOD activity might be a valuable and easily accessible tool for assessing and monitoring reduced LVEF in the diabetic patients with ACS.https://doi.org/10.1186/s12872-024-03867-2Superoxide dismutasesPatients with type 2 diabetes and acute coronary syndromeReduced left ventricular ejection fraction
spellingShingle Xiu-Yun Jiang
Qing Chen
Xiao-Yu Chen
Qiu-Ying Sun
Fei Jing
Hai-Qing Zhang
Jin Xu
Xiao-Hong Li
Qing-Bo Guan
Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
BMC Cardiovascular Disorders
Superoxide dismutases
Patients with type 2 diabetes and acute coronary syndrome
Reduced left ventricular ejection fraction
title Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
title_full Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
title_fullStr Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
title_full_unstemmed Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
title_short Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
title_sort superoxide dismutases marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome
topic Superoxide dismutases
Patients with type 2 diabetes and acute coronary syndrome
Reduced left ventricular ejection fraction
url https://doi.org/10.1186/s12872-024-03867-2
work_keys_str_mv AT xiuyunjiang superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT qingchen superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT xiaoyuchen superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT qiuyingsun superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT feijing superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT haiqingzhang superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT jinxu superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT xiaohongli superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome
AT qingboguan superoxidedismutasesmarkerinpredictingreducedleftventricularejectionfractioninpatientswithtype2diabetesandacutecoronarysyndrome